Evidence map›Paper›PMID 41488694›Full record

ArticleOpen forum infectious diseases2026

Maartje Visser, Helene C A Zondag, Birgit H B van Benthem, Corné H W Klaassen, Sylvia M Bruisten, Denise E Twisk, Suzanne Q van Veen, Henry J C de Vries, Petra F G Wolffs, Alje P van Dam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maartje VisserDepartment of Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.ORCID https://orcid.org/0000-0002-2607-7677
Helene C A ZondagDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Birgit H B van BenthemDepartment of Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Corné H W KlaassenDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Sylvia M BruistenDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Denise E TwiskDepartment of Public Health, Public Health Service Rotterdam, Rotterdam, the Netherlands.ORCID https://orcid.org/0000-0002-6131-9600
Suzanne Q van VeenDepartment of Medical Microbiology and Infection Prevention, Haaglanden Medical Centre, The Hague, the Netherlands.
Henry J C de VriesDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
Petra F G WolffsDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, Faculty of Health, Medicine and Life Sciences, Care and Public Health Research Institute, Maastricht University Medical Centre, Maastricht, the Netherlands.
Alje P van DamDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0003-3967-550X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since September 2022, an ongoing increase in gonorrhea positivity rates and diagnoses among young women visiting sexual health centers was observed in the Netherlands. To gain more insight into possible drivers of this increase, this study aimed to investigate the molecular diversity, clustering, and transmission of Methods: Between January 2022 and March 2023, viable and stored Results: The prevalence of ST7359 and ST7822 increased from <5% in the beginning of 2022 to ∼23% in 2023 and ST9363 from 6% to 14%. ST7359 and ST9363 were associated with hosts with university-level education and Dutch ethnicity. ST7359 and ST7822 also included large clusters of genetically related isolates (<6-gene difference). No indication for reduced antimicrobial susceptibility to ceftriaxone was found in any ST. Conclusions: The

Indexed as

epidemiologyNeisseria gonorrhoeaesequencingsexually transmitted infections

Identifiers

PMID41488694
PMCPMC12761311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.